| Ms Maria Arianna Maruffi, MD | |
|
2211 Lomas Blvd Ne, Albuquerque, NM 87106-2719 | |
| (505) 272-4461 | |
| Not Available |
| Full Name | Ms Maria Arianna Maruffi |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Hematology-oncology |
| Location | 2211 Lomas Blvd Ne, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609175918 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0207X | Pediatrics - Pediatric Hematology-oncology | MD2021-0873 (New Mexico) | Primary |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers.
Coronary CT angiography (CCTA) scans allow doctors to determine safely and more quickly which patients at low-to intermediate-risk for a heart attack can be discharged from hospital emergency departments (EDs) than traditional methods, according to the results of a large, multicenter American College of Radiology Imaging Network (ACRIN) trial published online today in the New England Journal of Medicine.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that University of Rochester Medical Center (URMC) has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
A new type of drug that helps target chemotherapy directly to cancer cells has been found to significantly increase survival of patients with the most common form of bladder cancer, according to results from a phase III clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust.
Healthcare leaders have learned that sometimes medical breakthroughs simply aren't enough. Patients can forget up to 80% of their doctor's instructions by the time they hit the parking lot. As a result, a lack of patient engagement creates a cascade of costs and negative outcomes ranging from readmissions, to poorly-managed chronic conditions, to medication non-adherence and more.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Maria Arianna Maruffi, MD Msc10 5590 1 University Of New Mexico, Albuquerque, NM 87131-0001 Ph: (505) 250-5497 | Ms Maria Arianna Maruffi, MD 2211 Lomas Blvd Ne, Albuquerque, NM 87106-2719 Ph: (505) 272-4461 |
News Archive
In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers.
Coronary CT angiography (CCTA) scans allow doctors to determine safely and more quickly which patients at low-to intermediate-risk for a heart attack can be discharged from hospital emergency departments (EDs) than traditional methods, according to the results of a large, multicenter American College of Radiology Imaging Network (ACRIN) trial published online today in the New England Journal of Medicine.
Acuo Technologies, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that University of Rochester Medical Center (URMC) has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution.
A new type of drug that helps target chemotherapy directly to cancer cells has been found to significantly increase survival of patients with the most common form of bladder cancer, according to results from a phase III clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust.
Healthcare leaders have learned that sometimes medical breakthroughs simply aren't enough. Patients can forget up to 80% of their doctor's instructions by the time they hit the parking lot. As a result, a lack of patient engagement creates a cascade of costs and negative outcomes ranging from readmissions, to poorly-managed chronic conditions, to medication non-adherence and more.
› Verified 7 days ago
Janell Fuller, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3rd Ambulatory Care Ctr, 2211 Lomas Blvd. Ne, Albuquerque, NM 87131 Phone: 505-272-2345 | |
Ivana Radovanovic, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2211 Lomas Ne Acc 3w, Albuquerque, NM 87131 Phone: 505-272-6632 Fax: 505-272-6620 | |
Lynn Longfield, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4420 Irving Blvd Nw, Albuquerque, NM 87114 Phone: 505-823-1010 Fax: 505-797-4503 | |
Thomas Rothfeld, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 401 San Mateo Blvd Se, Pmg San Mateo, Albuquerque, NM 87108 Phone: 505-462-7306 Fax: 505-462-7495 | |
Dr. Leslie Erin Strickler, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 505-272-5551 Fax: 505-272-6845 | |
Jennifer M Garcia, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2001 El Centro Familiar Blvd Sw, Albuquerque, NM 87105 Phone: 505-873-7400 Fax: 505-224-8797 | |
Dr. William B Hawk, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5904 Holly Ave Ne, Albuquerque, NM 87113 Phone: 505-298-2505 Fax: 505-298-2985 |